Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-12-19T10:04:43+0000
CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.
I'm a little template short and blank. I link to void and keep hidden out.
2024-12-19T10:04:43+0000
ResMed shares surge to a one-year high following impressive 4Q earnings and a 10% dividend increase. With analysts rating the stock a "BUY", CEO Mick Farrell views the impact of weight loss drugs as a growth opportunity.
2024-08-07T01:33:30+0100
ResMed reports a significant revenue rise of 9% to $1.22 billion USD in the June quarter, highlighting its strong market position despite concerns over weight loss drugs impacting product demand.
2024-08-05T08:13:42+0100